English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/27252
logo share SHARE   Add this article to your Mendeley library MendeleyBASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:


Immunosuppressor based on the interruption of TCR_NCK interaction

Other TitlesInmunosupresor basado en la interrupción de la interacción TCR-Nck
AuthorsAlarcón, Balbino ; Ramírez Ortiz, Miguel Ángel; Borroto Revuelta, Aldo ; Morreale, Antonio
Issue Date7-Jan-2010
CitationWO2010000900 A1
Abstract[EN] The invention relates to a compound of structural formula (1) and the derivatives thereof, for the use thereof as a medicament, preferably as an immunosuppressive agent based on the interruption of TCR-Nck interaction.
[ES] La presente invención se refiere a un compuesto de fórmula estructural (1) y sus derivados, para su uso como medicamento. Preferiblemente como agente inmunosupresor basado en la interrupción de la interacción TCR-Nck.
Appears in Collections:(CBM) Patentes
Files in This Item:
File Description SizeFormat 
WO2010000900A1.pdf1,05 MBAdobe PDFThumbnail
Show full item record
Review this work

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.